Quarterly report pursuant to Section 13 or 15(d)

Description of Business

 v2.3.0.11
Description of Business
6 Months Ended
Jun. 30, 2011
Description of Business [Abstract]  
Description of Business
1.  Description of Business

XOMA Ltd. (“XOMA” or the “Company”), a Bermuda company, is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies designed to treat inflammatory, autoimmune, infectious and oncological diseases. The Company's products are presently in various stages of development and are subject to regulatory approval before they can be commercially launched.